Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-13 · accession 0001787306-24-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-15 | 2024-02-13 | ARQT | Smither John W | CFO | A - Grant | — | +11.4K | 11.4K | New | — |
| DM | 2024-02-15 | 2024-02-13 | ARQT | Smither John W | CFO | D - Sale to Iss | — | -34.1K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-13 | A | A | 2,793 | — | 2,793 | D | — | — | (F1) On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on February 27, 2020, and received in exchange for the option, these Restricted Stock Units ("RSUs") that vest in four equal quarterly installments commencing May 1, 2024. |
| 2 | Common | Common Stock | 2024-02-13 | A | A | 8,572 | — | 11,365 | D | — | — | (F2) On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2021, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024. |
| 3 | Derivative | Stock Option (right to buy) | 2024-02-13 | D | D | 8,379 | — | 0 | D | $27.61 · — to 2025-03-31 | 8,379 Common Stock | (F1) On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on February 27, 2020, and received in exchange for the option, these Restricted Stock Units ("RSUs") that vest in four equal quarterly installments commencing May 1, 2024. (F4) This option is fully vested. |
| 4 | Derivative | Stock Option (right to buy) | 2024-02-13 | D | D | 25,718 | — | 0 | D | $32.44 · — to 2025-03-31 | 25,718 Common Stock | (F2) On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2021, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024. (F5) This option is fully vested. |